15
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Multiple Myeloma: Expression of Nucleoside Transporters on Malignant Plasma Cells and Their Relationship to Cellular Proliferation

, , , , , , & show all
Pages 491-499 | Received 03 Aug 1993, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

B. Pope, R. D. Brown, J. Gibson, A. Petersen, J. Wiley & D. E. Joshua. (1997) The Functional Phenotype of the Primitive Plasma Cell in Patients with Multiple Myeloma Correlates with the Clinical State. Leukemia & Lymphoma 27:1-2, pages 83-91.
Read now

Articles from other publishers (6)

Laura Chow, Raymond Lai, Laith Dabbagh, Andrew Belch, James D Young, Carol E Cass & John R Mackey. (2005) Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry. Modern Pathology 18:4, pages 558-564.
Crossref
Andrew D. Clark, Kenneth W. Douglas, Lyndsay D. Mitchell, I. Grant McQuaker, Anne N. Parker, Patrick J. Tansey, Ian M. Franklin & Gordon Cook. (2002) Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment. British Journal of Haematology 117:3, pages 605-612.
Crossref
CM Galmarini, JR Mackey & C Dumontet. (2001) Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 15:6, pages 875-890.
Crossref
Amarette J. Petersen, Ross D. Brown, John Gibson, Belinda Pope, Xiao‐Feng Luo, Leonard Schutz, James S. Wiley & Douglas E. Joshua. (2009) Nucleoside transporters, bcl‐2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro . European Journal of Haematology 56:4, pages 213-220.
Crossref
Douglas E. Joshua, Ross D. Brown & John Gibson. (2008) MULTIPLE MYELOMA: WHY DOES THE DISEASE ESCAPE FROM PLATEAU PHASE?. British Journal of Haematology 88:4, pages 667-671.
Crossref
D.E. Joshua, J. Gibson & R.D. Brown. (1994) Mechanisms of the escape phase of myeloma. Blood Reviews 8:1, pages 13-20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.